2-(Aminoalkyl)-5-nitropyrazolo[3,4,5-kl]acridines, a new class of anticancer agents
摘要:
2-(Aminoalkyl)-5-nitropyrazolo[3,4,5-kl]acridines were prepared from substituted anilines via the 1-chloro-4-nitroacridones followed by condensation with [(alkylamino)alkyl]hydrazines. Impressive activity was demonstrated for the 9-hydroxy, 9-alkoxy, and 9-acyloxy analogs in vitro on a L1210 leukemia line and in vivo against the P388 leukemia. Advanced studies led to the selection of 3bbb for clinical trial.
Pyrazolo[3,4,5-kl]acridine compositions and methods for their production
申请人:Warner-Lambert Company
公开号:US04555572A1
公开(公告)日:1985-11-26
Pyrazolo[3,4,5-kl]acridines are described as antibacterial agents and antitumor agents as well as pharmaceutical compositions and methods for their preparation.
吡唑并[3,4,5-kl]蒽啉被描述为抗菌剂和抗肿瘤剂,以及它们的制备方法和药物组合物。
Substituted 1-amino-4-nitro-acridinones and methods of treating
申请人:Warner-Lambert Company
公开号:US04626540A1
公开(公告)日:1986-12-02
Substituted 1-amino-4-nitroacridinones, their method of manufacture, pharmaceutical compositions and their use as antibacterial and antitumor agents are herein described.
本文描述了1-氨基-4-硝基蒽醌酮及其制备方法、药物组合物以及作为抗菌和抗肿瘤剂的用途。
Pyrazolo[3,4,5-k1]acridine compositions and methods for their use as
申请人:Warner-Lambert Company
公开号:US04588730A1
公开(公告)日:1986-05-13
Pyrazolo[3,4,5-k1]acridines are described as antibacterial agents and antitumor agents as well as pharmaceutical compositions and methods for their preparation.
Method of treating leukemia with pyrazolo[3,4,5-kl]acridines
申请人:Warner-Lambert Company
公开号:US04621086A1
公开(公告)日:1986-11-04
Pyrazolo[3,4,5-kl]acridines are described as antibacterial agents and antitumor agents as well as pharmaceutical compositions and methods for their preparation.
Substituted 1-amino-4-nitro-acridinones, pharmaceutical compositions comprising the same and processes for their production
申请人:WARNER-LAMBERT COMPANY
公开号:EP0145226A2
公开(公告)日:1985-06-19
Substituted 1-Amino-4-nitroacridinones of formula
as antibacterial and antitumor agents are herein described. Also disclosed are processes for their production and pharmaceutical compositions comprising the new compounds.